BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Immuron Joins International OTCQX


2/10/2009 12:18:32 PM

NEW YORK, NY--(Marketwire - February 10, 2009) - Pink OTC Markets Inc., the leading electronic inter-dealer quotation system, trading technology and financial information provider for over-the-counter (OTC) securities, today announced that Immuron (PINKSHEETS: IMROY) (OTCQX: IMROY) (ASX: IMC), an Australian biotechnology company focused on oral immunotherapeutic products, has chosen to list its American Depositary Receipts (ADRs) on International OTCQX. Immuron's ADRs began trading today on the OTC market's prestigious tier, International PrimeQX. Investors can find current disclosure and financial information for the company on www.otcqx.com and www.pinksheets.com.

"As an OTCQX-listed company, Immuron distinguishes itself from the thousands of other companies traded over-the-counter and is associated with many of the most prestigious companies in our marketplace," said R. Cromwell Coulson, Chairman and CEO of Pink OTC Markets. "We welcome them to the International OTCQX market tier."

The Bank of New York Mellon will serve as Immuron's Principal American Liaison ("PAL") on the International OTCQX, responsible for providing guidance on listing requirements.

Immuron's ADRs will trade in the United States on International OTCQX under the ticker "IMROY" where each ADR will represent twenty ordinary shares. Immuron's shares are also listed on the Australian Securities Exchange (ASX). The company's headquarters are in Melbourne, Australia.

About Immuron

Immuron (PINKSHEETS: IMROY) (OTCQX: IMROY) (ASX: IMC) is an Australian biotechnology company with proprietary and proven commercial biotechnology for producing oral immunotherapeutic products. Their current commercial products and emerging research pipeline include products that contain antigen targeted antibodies and other proteins, to address a range gastrointestinal, infectious and immune-mediated diseases. Product pipeline includes solutions addressing Flu, HIV, Cancer related Mucositis, Diabetes and Metabolic Syndrome, and e.coli. For more about Immuron visit www.immuron.com.

For Investor relations inquiries, contact Dr. Oren Fuerst: oren@immuron.com

About International OTCQX

International OTCQX provides a gateway to U.S. securities markets for international companies that are listed on a qualified non-U.S. exchange and provide ongoing disclosure in English to U.S. investors. More importantly, International OTCQX distinguishes the reputable international issuers from the 8,000 over-the-counter (OTC) securities traded in the U.S. Only leading companies that have substantial operating businesses and provide credible disclosure to the public are eligible for inclusion on the premium-tier International OTCQX, which commenced trading on March 5, 2007. For more about International OTCQX, visit www.otcqx.com.

About Pink OTC Markets Inc.

Pink OTC Markets Inc. provides the leading inter-dealer electronic quotation and trading system in the over-the-counter (OTC) securities market. We create innovative technology and data solutions to efficiently connect market participants, improve price discovery, increase issuer disclosure, and better inform investors. Pink OTC Markets operates the third largest U.S. equity trading venue which includes both the elite OTCQX market tiers for strong OTC-traded companies that can satisfy financial and disclosure listing standards and Pink Sheets for all other OTC quoted securities.

Over 230 financial service firms, including the ten largest U.S. investment banks, actively make markets in OTCQX and Pink Sheets quoted securities and in 2007 these firms traded over $160 billion of OTCQX and Pink Sheets securities. Pink OTC Markets offers widespread access to all U.S. broker-dealers, enabling investors to seamlessly trade these securities through their institutional, online, or full service brokers.

Pink OTC Markets is headquartered in New York City.

To learn more about how Pink OTC Markets' products and services make OTC markets more transparent, informed, and efficient, please visit our websites at www.pinkotc.com, www.pinksheets.com and www.otcqx.com or contact us at info@pinkotc.com.


Media Contact:
Chris Moore
CCG Investor Relations
+1 (646) 454-4519
Christopher.Moore@ccgir.com


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->